Gradient Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.8M Buy
152,831
+13,737
+10% +$3.2M 0.54% 58
2026
Q1
$34M Sell
139,094
-12,768
-8% -$2.97M 0.53% 59
2025
Q4
$31.4M Sell
151,862
-75,687
-33% -$15M 0.5% 63
2025
Q3
$42.2M Buy
227,549
+5,377
+2% +$921K 0.7% 40
2025
Q2
$33.9M Buy
222,172
+1,923
+0.9% +$296K 0.62% 51
2025
Q1
$36.5M Buy
220,249
+7,641
+4% +$1.2M 0.74% 45
2024
Q4
$30.7M Sell
212,608
-12,812
-6% -$1.99M 0.62% 48
2024
Q3
$36.5M Sell
225,420
-12,788
-5% -$2.04M 0.76% 41
2024
Q2
$34.8M Buy
238,208
+19,345
+9% +$2.88M 0.78% 38
2024
Q1
$34.6M Buy
218,863
+1,819
+0.8% +$290K 0.8% 30
2023
Q4
$34M Buy
217,044
+9,597
+5% +$1.47M 0.82% 31
2023
Q3
$32.3M Buy
207,447
+5,988
+3% +$988K 0.85% 30
2023
Q2
$33.3M Buy
201,459
+19,046
+10% +$3.07M 0.86% 28
2023
Q1
$28.3M Buy
182,413
+42,108
+30% +$6.8M 0.77% 31
2022
Q4
$24.8M Sell
140,305
-572
-0.4% -$98.8K 0.78% 30
2022
Q3
$23M Buy
140,877
+9,849
+8% +$1.67M 0.7% 29
2022
Q2
$23.3M Sell
131,028
-12,874
-9% -$2.29M 0.68% 26
2022
Q1
$25.5M Sell
143,902
-10,292
-7% -$1.75M 0.66% 33
2021
Q4
$26.4M Buy
154,194
+9,831
+7% +$1.61M 0.67% 33
2021
Q3
$23.3M Buy
144,363
+18,010
+14% +$3.07M 0.65% 30
2021
Q2
$20.8M Buy
126,353
+5,530
+5% +$916K 0.61% 30
2021
Q1
$19.9M Buy
120,823
+12,495
+12% +$2.02M 0.65% 28
2020
Q4
$16.1M Sell
108,328
-1,059
-1% -$156K 0.68% 29
2020
Q3
$16.3M Buy
109,387
+11,103
+11% +$1.64M 0.68% 30
2020
Q2
$13.8M Sell
98,284
-2,378
-2% -$347K 0.63% 34
2020
Q1
$13.2M Buy
100,662
+5,973
+6% +$847K 0.71% 23
2019
Q4
$13.8M Buy
94,689
+4,505
+5% +$611K 0.62% 30
2019
Q3
$11.7M Buy
90,184
+7,939
+10% +$1.05M 0.57% 33
2019
Q2
$11.5M Buy
82,245
+18,556
+29% +$2.57M 0.59% 30
2019
Q1
$8.9M Sell
63,689
-6,563
-9% -$879K 0.58% 31
2018
Q4
$9.07M Sell
70,252
-4,947
-7% -$690K 0.54% 34
2018
Q3
$10.4M Buy
75,199
+3,750
+5% +$498K 0.53% 33
2018
Q2
$8.67M Buy
71,449
+4,339
+6% +$541K 0.46% 52
2018
Q1
$8.6M Buy
67,110
+5,835
+10% +$789K 0.47% 48
2017
Q4
$8.56M Buy
61,275
+2,933
+5% +$409K 0.49% 34
2017
Q3
$7.58M Buy
58,342
+1,941
+3% +$257K 0.48% 41
2017
Q2
$7.46M Buy
56,401
+3,483
+7% +$444K 0.52% 33
2017
Q1
$6.59M Buy
52,918
+6,454
+14% +$771K 0.5% 39
2016
Q4
$5.35M Buy
46,464
+4,252
+10% +$491K 0.47% 55
2016
Q3
$4.99M Buy
42,212
+2,540
+6% +$308K 0.49% 44
2016
Q2
$4.81M Buy
39,672
+2,582
+7% +$293K 0.52% 30
2016
Q1
$4.01M Sell
37,090
-2,826
-7% -$293K 0.5% 49
2015
Q4
$4.1M Buy
39,916
+407
+1% +$40.9K 0.55% 28
2015
Q3
$3.69M Sell
39,509
-1,695
-4% -$164K 0.52% 31
2015
Q2
$4.02M Buy
41,204
+3,639
+10% +$364K 0.55% 35
2015
Q1
$3.78M Buy
37,565
+36,243
+2,742% +$3.69M 0.56% 37
2014
Q4
$138K Sell
1,322
-27,163
-95% -$2.86M 0.02% 172
2014
Q3
$3.04M Buy
28,485
+2,670
+10% +$277K 0.55% 33
2014
Q2
$2.7M Buy
25,815
+3,086
+14% +$312K 0.53% 36
2014
Q1
$2.23M Buy
22,729
+21,310
+1,502% +$1.98M 0.52% 35
2013
Q4
$130K Buy
1,419
+55
+4% +$5.07K 0.03% 174
2013
Q3
$118K Sell
1,364
-13,618
-91% -$1.22M 0.04% 147
2013
Q2
$1.29M Buy
+14,982
New +$1.27M 0.48% 40

Other funds holding JNJ

Gradient Investments's JNJ Position: Q2 2026 in Review

Gradient Investments increased its Johnson & Johnson (JNJ) stake by 9.9% in Q2 2026, buying an estimated $3.2M and bringing the position to 152,831 shares worth $38.8M. The position accounts for 0.54% of the portfolio, ranked #58.

Gradient Investments first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $42.2M in Q3 2025. 1,243 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gradient Investments held 152,831 shares of Johnson & Johnson worth $38.8M as of Q2 2026.
  • Gradient Investments bought 13,737 Johnson & Johnson shares in Q2 2026, an estimated $3.2M.
  • Johnson & Johnson made up 0.54% of Gradient Investments's portfolio in Q2 2026, its #58 holding.
  • Gradient Investments first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Gradient Investments's Johnson & Johnson position peaked at $42.2M in Q3 2025.
  • 1,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.